{"id":461,"date":"2026-02-28T09:28:45","date_gmt":"2026-02-28T09:28:45","guid":{"rendered":"https:\/\/heartcareforyou.in\/blog\/sick-sinus-syndrome-definition-clinical-context-and-cardiology-overview\/"},"modified":"2026-02-28T09:28:45","modified_gmt":"2026-02-28T09:28:45","slug":"sick-sinus-syndrome-definition-clinical-context-and-cardiology-overview","status":"publish","type":"post","link":"https:\/\/heartcareforyou.in\/blog\/sick-sinus-syndrome-definition-clinical-context-and-cardiology-overview\/","title":{"rendered":"Sick Sinus Syndrome: Definition, Clinical Context, and Cardiology Overview"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Sick Sinus Syndrome Introduction (What it is)<\/h2>\n\n\n\n<p>Sick Sinus Syndrome is a condition where the heart\u2019s natural pacemaker does not consistently generate or transmit normal impulses.<br\/>\nIt is a cardiac conduction disorder rather than a single rhythm diagnosis.<br\/>\nIt is commonly encountered when evaluating bradycardia (slow heart rate), syncope (fainting), dizziness, or unexplained fatigue.<br\/>\nIt often arises in ambulatory ECG monitoring and electrophysiology-oriented cardiology care.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why Sick Sinus Syndrome matters in cardiology (Clinical relevance)<\/h2>\n\n\n\n<p>Sick Sinus Syndrome matters because the sinus node normally sets the pace for coordinated atrial and ventricular contraction, supporting stable cardiac output during rest and activity. When sinus node function is impaired, patients may experience symptoms related to low heart rate, pauses, or an inadequate heart-rate response to exertion (chronotropic incompetence). In some cases, the syndrome alternates between slow rhythms and atrial tachyarrhythmias such as atrial fibrillation (AF), which can complicate evaluation and treatment planning.<\/p>\n\n\n\n<p>From a clinical reasoning standpoint, Sick Sinus Syndrome is important for diagnostic clarity: symptoms like lightheadedness, falls, confusion, and exercise intolerance are nonspecific and may reflect cardiac, neurologic, medication-related, or systemic causes. Establishing (or excluding) a rhythm correlation can meaningfully change management, including decisions about pacing, medication choices, and stroke prevention strategies when AF is present.<\/p>\n\n\n\n<p>In education and practice, Sick Sinus Syndrome is also a gateway concept for understanding how intrinsic conduction disease interacts with extrinsic influences (autonomic tone, medications, metabolic factors) and why an electrocardiogram (ECG) snapshot can miss intermittent pathology. It illustrates the principle that symptoms and rhythm documentation need to be interpreted together, not in isolation.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Classification \/ types \/ variants<\/h2>\n\n\n\n<p>Sick Sinus Syndrome is a clinical umbrella term rather than a single ECG pattern. Clinicians commonly categorize it by the dominant manifestation, which helps guide evaluation and treatment discussions:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\n<p><strong>Sinus bradycardia<\/strong><br\/>\n  Persistent or intermittent slow sinus rates that may be inappropriate for the clinical context (for example, symptoms at modest heart rates, or bradycardia without an expected physiologic trigger).<\/p>\n<\/li>\n<li>\n<p><strong>Sinus pauses or sinus arrest<\/strong><br\/>\n  Transient failure of impulse generation from the sinus node leading to pauses; the clinical significance often depends on symptom correlation and the presence of reliable escape rhythms.<\/p>\n<\/li>\n<li>\n<p><strong>Sinoatrial (SA) exit block<\/strong><br\/>\n  The sinus node generates impulses, but conduction from the node to surrounding atrial tissue is intermittently blocked. On surface ECG, this can resemble pauses and may be difficult to distinguish from sinus arrest without careful pattern analysis.<\/p>\n<\/li>\n<li>\n<p><strong>Tachy\u2013brady syndrome<\/strong><br\/>\n  Alternation between atrial tachyarrhythmias (commonly AF, atrial flutter, or atrial tachycardia) and clinically significant sinus bradycardia or pauses, sometimes after termination of the tachyarrhythmia.<\/p>\n<\/li>\n<li>\n<p><strong>Chronotropic incompetence<\/strong><br\/>\n  Inadequate increase in heart rate with exertion, leading to exercise intolerance. Definitions and testing approaches vary by clinician and case.<\/p>\n<\/li>\n<\/ul>\n\n\n\n<p>These variants can overlap in the same patient over time. The label \u201cSick Sinus Syndrome\u201d generally implies clinically meaningful dysfunction, not simply a slow heart rate in a well-conditioned person or during sleep.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Relevant anatomy &amp; physiology<\/h2>\n\n\n\n<p>Understanding Sick Sinus Syndrome starts with the normal cardiac conduction system:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\n<p><strong>Sinus node (sinoatrial node)<\/strong><br\/>\n  A cluster of pacemaker cells located in the high right atrium near the superior vena cava. It initiates the electrical impulse that spreads through the atria, producing the P wave on the ECG.<\/p>\n<\/li>\n<li>\n<p><strong>Atrial conduction and atrioventricular (AV) node<\/strong><br\/>\n  After atrial activation, the impulse reaches the AV node, which delays conduction before passing it to the His\u2013Purkinje system and the ventricles. In Sick Sinus Syndrome, the primary issue is usually upstream (sinus node impulse generation or its exit to the atrium), though coexisting AV conduction disease can occur.<\/p>\n<\/li>\n<li>\n<p><strong>Autonomic regulation<\/strong><br\/>\n  Sympathetic stimulation increases sinus node firing (higher heart rate) and improves chronotropic response; parasympathetic (vagal) tone slows sinus node firing. Many patients have a mixture of intrinsic node disease and extrinsic autonomic influences.<\/p>\n<\/li>\n<li>\n<p><strong>Blood supply<\/strong><br\/>\n  The sinus node receives arterial blood supply that may arise from the right coronary artery (RCA) or the left circumflex artery (LCx), depending on anatomic variation. Ischemia affecting these branches can contribute to sinus node dysfunction in some contexts.<\/p>\n<\/li>\n<\/ul>\n\n\n\n<p>Physiologically, the sinus node acts as the heart\u2019s primary clock. When it slows excessively, pauses, or fails to respond appropriately to activity, cardiac output may drop\u2014especially in people who cannot compensate with increased stroke volume or peripheral vascular adjustments.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Pathophysiology or mechanism<\/h2>\n\n\n\n<p>The core mechanism in Sick Sinus Syndrome is impaired sinus node automaticity and\/or impaired conduction of impulses from the sinus node into atrial tissue. The underlying drivers can be intrinsic (structural) or extrinsic (functional), and more than one factor is often present.<\/p>\n\n\n\n<p>Common mechanistic contributors include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\n<p><strong>Age-related fibrosis and degenerative change<\/strong><br\/>\n  Progressive fibrotic remodeling of the sinus node and surrounding atrial tissue can reduce pacemaker cell function and disrupt impulse exit pathways. This is a frequent context in older adults.<\/p>\n<\/li>\n<li>\n<p><strong>Atrial remodeling and \u201catrial myopathy\u201d<\/strong><br\/>\n  Conditions that enlarge or scar the atria (for example, long-standing hypertension, valvular disease, heart failure, or recurrent atrial tachyarrhythmias) may be associated with both Sick Sinus Syndrome and AF, reflecting shared substrate rather than two unrelated diagnoses.<\/p>\n<\/li>\n<li>\n<p><strong>Ischemia or infarction affecting sinus node tissue or its arterial supply<\/strong><br\/>\n  This is not the most common mechanism overall, but it may be relevant in acute coronary syndromes or significant coronary disease involving the sinus node artery.<\/p>\n<\/li>\n<li>\n<p><strong>Medication effects (extrinsic suppression of the sinus node)<\/strong><br\/>\n  Drugs that slow nodal activity or conduction can unmask or worsen sinus node dysfunction. Common classes include beta blockers, non-dihydropyridine calcium channel blockers, digoxin, certain antiarrhythmic agents, and other agents that influence autonomic tone. The degree of effect varies by patient factors and protocol.<\/p>\n<\/li>\n<li>\n<p><strong>Metabolic and systemic contributors<\/strong><br\/>\n  Hypothyroidism, electrolyte disturbances, hypothermia, and sleep-disordered breathing can be associated with bradyarrhythmias and may overlap with or mimic Sick Sinus Syndrome.<\/p>\n<\/li>\n<li>\n<p><strong>Inflammatory, infiltrative, or post-procedural causes<\/strong><br\/>\n  Myocarditis, infiltrative cardiomyopathies, or surgical\/ablative injury near the right atrium can affect sinus node function in some cases.<\/p>\n<\/li>\n<\/ul>\n\n\n\n<p>Because the syndrome is often intermittent, the mechanism can appear \u201con and off\u201d clinically\u2014especially when autonomic tone fluctuates, medications change, or atrial tachyarrhythmias begin or terminate.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical presentation or indications<\/h2>\n\n\n\n<p>Sick Sinus Syndrome is typically suspected in patients with symptoms suggestive of intermittent bradycardia, pauses, or an inadequate heart-rate response. Common clinical scenarios include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Episodic <strong>lightheadedness<\/strong>, presyncope, or <strong>syncope<\/strong><\/li>\n<li><strong>Fatigue<\/strong> or reduced stamina with daily activities<\/li>\n<li><strong>Exercise intolerance<\/strong>, particularly when the heart rate does not rise appropriately with exertion<\/li>\n<li><strong>Palpitations<\/strong> in tachy\u2013brady syndrome (often related to AF or atrial flutter)<\/li>\n<li><strong>Falls<\/strong> or near-falls in older adults with unclear cause<\/li>\n<li><strong>Confusion<\/strong> or cognitive \u201cfog\u201d temporally associated with bradycardia (nonspecific; requires careful evaluation)<\/li>\n<li>Symptoms that occur <strong>after termination of AF or atrial tachycardia<\/strong>, when prolonged pauses can occur<\/li>\n<li>Incidentally noted <strong>bradycardia<\/strong> on ECG or wearable data, followed by symptom correlation workup (wearable alerts alone are not diagnostic)<\/li>\n<\/ul>\n\n\n\n<p>Some patients are minimally symptomatic or adapt their activity to avoid provoking symptoms, which can delay recognition.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Diagnostic evaluation &amp; interpretation<\/h2>\n\n\n\n<p>Diagnosis is usually clinical and rhythm-based: clinicians aim to document sinus node dysfunction and correlate it with symptoms, while excluding reversible contributors and alternative causes.<\/p>\n\n\n\n<p>Typical evaluation components include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>History and symptom characterization<\/strong><\/li>\n<li>Timing, triggers (rest, sleep, post-exertion), and associated features (palpitations, chest discomfort, dyspnea).<\/li>\n<li>Medication review is essential, including rate-slowing agents and recent dose changes.<\/li>\n<li>\n<p>Screening for sleep-disordered breathing may be considered when nocturnal bradycardia or pauses are prominent, depending on clinical context.<\/p>\n<\/li>\n<li>\n<p><strong>Physical examination<\/strong><\/p>\n<\/li>\n<li>Resting pulse characteristics (slow, irregular).<\/li>\n<li>\n<p>Signs of structural heart disease or heart failure that could suggest broader cardiac substrate.<\/p>\n<\/li>\n<li>\n<p><strong>12-lead ECG<\/strong><\/p>\n<\/li>\n<li>May show sinus bradycardia, pauses, junctional escape rhythms, or atrial arrhythmias.<\/li>\n<li>\n<p>A normal ECG does not exclude intermittent Sick Sinus Syndrome.<\/p>\n<\/li>\n<li>\n<p><strong>Ambulatory rhythm monitoring<\/strong><\/p>\n<\/li>\n<li><strong>Holter monitor<\/strong> (continuous monitoring over a short window) may capture frequent events.<\/li>\n<li><strong>Event monitors<\/strong> or patch monitors may be used for less frequent symptoms.<\/li>\n<li>\n<p><strong>Implantable loop recorders<\/strong> may be considered when symptoms are infrequent but concerning (for example, unexplained syncope), depending on clinician judgment and local practice.<\/p>\n<\/li>\n<li>\n<p><strong>Laboratory assessment (selected, case-dependent)<\/strong><\/p>\n<\/li>\n<li>\n<p>Thyroid function, electrolytes, and other tests guided by presentation; exact panels vary by protocol and patient factors.<\/p>\n<\/li>\n<li>\n<p><strong>Echocardiography<\/strong><\/p>\n<\/li>\n<li>\n<p>Not required to diagnose sinus node dysfunction, but often used to assess for structural heart disease (chamber size, ventricular function, valvular disease) that may influence overall management.<\/p>\n<\/li>\n<li>\n<p><strong>Exercise testing (selected cases)<\/strong><\/p>\n<\/li>\n<li>\n<p>May help evaluate chronotropic response when exertional symptoms dominate and resting ECG is nondiagnostic.<\/p>\n<\/li>\n<li>\n<p><strong>Electrophysiology (EP) study<\/strong><\/p>\n<\/li>\n<li>Invasive testing can measure sinus node recovery and conduction properties, but it is not routinely required. Use varies by clinician and case, particularly when noninvasive evaluation is inconclusive.<\/li>\n<\/ul>\n\n\n\n<p>Interpretation emphasizes <em>symptom\u2013rhythm correlation<\/em>. A slow rate or pause can be physiologic in some situations (sleep, high vagal tone, endurance athletes). Conversely, relatively modest bradycardia can be clinically significant in a symptomatic patient or in someone with limited compensatory reserve.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Management overview (General approach)<\/h2>\n\n\n\n<p>Management is individualized and generally centers on (1) identifying reversible contributors, (2) treating associated atrial tachyarrhythmias when present, and (3) considering pacing when bradyarrhythmia-related symptoms are documented.<\/p>\n\n\n\n<p>High-level approaches include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Address potentially reversible or contributing factors<\/strong><\/li>\n<li>Review and adjust medications that may suppress sinus node function when clinically appropriate.<\/li>\n<li>Correct metabolic contributors (for example, thyroid or electrolyte abnormalities) when present.<\/li>\n<li>\n<p>Evaluate comorbid conditions that can worsen bradyarrhythmias (for example, sleep-disordered breathing), as guided by clinical context.<\/p>\n<\/li>\n<li>\n<p><strong>Observation and monitoring<\/strong><\/p>\n<\/li>\n<li>If symptoms are absent or correlation is unclear, clinicians may pursue additional rhythm monitoring rather than immediate intervention.<\/li>\n<li>\n<p>Follow-up strategy and monitoring intensity vary by clinician and case.<\/p>\n<\/li>\n<li>\n<p><strong>Permanent pacemaker therapy (device-based support)<\/strong><\/p>\n<\/li>\n<li>For patients with <em>documented symptomatic<\/em> sinus node dysfunction, pacing may be considered to prevent clinically significant bradycardia and pauses.<\/li>\n<li>\n<p>Device selection (single-chamber atrial, dual-chamber, rate-responsive features) depends on rhythm status, AV conduction, comorbidities, and clinician preference. In many real-world scenarios, dual-chamber or atrial-based pacing strategies are considered to maintain physiologic timing, but specific choices vary.<\/p>\n<\/li>\n<li>\n<p><strong>Managing tachy\u2013brady syndrome<\/strong><\/p>\n<\/li>\n<li>AF or atrial flutter management (rate control, rhythm control, or ablation strategies) may be part of care.<\/li>\n<li>A pacemaker can sometimes facilitate safer use of medications that would otherwise worsen bradycardia, but the overall approach depends on patient factors and clinician judgment.<\/li>\n<li>\n<p>Stroke prevention for AF is typically guided by established risk stratification frameworks; specific anticoagulation decisions are individualized.<\/p>\n<\/li>\n<li>\n<p><strong>Shared decision-making<\/strong><\/p>\n<\/li>\n<li>Symptom burden, comorbidities, lifestyle considerations, and procedural risks are weighed together. The \u201cright\u201d plan may differ across patients with similar ECG findings.<\/li>\n<\/ul>\n\n\n\n<p>This overview is educational; specific treatment choices are clinical decisions made by qualified professionals based on the full context.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Complications, risks, or limitations<\/h2>\n\n\n\n<p>Risks and limitations relate both to the syndrome itself and to interventions commonly used in its management.<\/p>\n\n\n\n<p><strong>Potential complications of Sick Sinus Syndrome (condition-related):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Syncope or near-syncope<\/strong>, with secondary risks such as falls or injury<\/li>\n<li><strong>Reduced functional capacity<\/strong> from chronotropic incompetence<\/li>\n<li><strong>Atrial fibrillation and other atrial tachyarrhythmias<\/strong>, which may increase thromboembolic risk depending on overall risk profile<\/li>\n<li><strong>Heart failure symptom exacerbation<\/strong> in some patients, particularly when bradycardia limits cardiac output (context-dependent)<\/li>\n<\/ul>\n\n\n\n<p><strong>Limitations in diagnosis:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The disorder is often <strong>intermittent<\/strong>, so short ECG recordings may miss it.<\/li>\n<li><strong>Nocturnal bradycardia<\/strong> and pauses can be physiologic in some people, complicating interpretation.<\/li>\n<li>Wearables can suggest bradycardia but may have <strong>false positives\/negatives<\/strong> and typically require medical-grade confirmation.<\/li>\n<\/ul>\n\n\n\n<p><strong>Risks related to pacemakers (if used):<\/strong><br\/>\nThese vary by device type, implant technique, and patient factors, but may include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Infection, bleeding, hematoma, or pain at the implant site<\/li>\n<li>Lead-related issues (dislodgement, fracture) for transvenous systems<\/li>\n<li>Pneumothorax or vascular complications during implantation (uncommon but recognized)<\/li>\n<li>Need for future generator replacement and long-term device follow-up<\/li>\n<li>Pacing-related changes in cardiac activation that may affect some patients (context-dependent)<\/li>\n<\/ul>\n\n\n\n<p><strong>Medication-related risks (when treating associated arrhythmias):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Rate-slowing drugs may worsen bradycardia or pauses in susceptible individuals.<\/li>\n<li>Antiarrhythmic drugs can carry proarrhythmic or organ-specific risks; selection varies by protocol and patient factors.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Prognosis &amp; follow-up considerations<\/h2>\n\n\n\n<p>Prognosis in Sick Sinus Syndrome depends on the underlying cause, coexisting structural heart disease, presence of atrial arrhythmias, and the degree of symptom burden. In many patients, symptoms related to bradycardia and pauses can improve when the rhythm abnormality is appropriately addressed, including with pacing when indicated. However, pacing supports heart rate and timing; it does not reverse atrial disease or eliminate AF risk.<\/p>\n\n\n\n<p>Follow-up commonly includes:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Rhythm surveillance<\/strong> for recurrent bradycardia, atrial tachyarrhythmias, or symptom recurrence, tailored to the clinical scenario.<\/li>\n<li><strong>Assessment of comorbidities<\/strong> that influence outcomes (heart failure, coronary disease, sleep-disordered breathing, thyroid disease).<\/li>\n<li><strong>Device follow-up<\/strong> when a pacemaker is present, including periodic checks of battery status, sensing\/pacing thresholds, and recorded arrhythmia episodes.<\/li>\n<li><strong>Ongoing risk assessment for AF-related complications<\/strong>, particularly thromboembolism risk, guided by clinician evaluation and established frameworks.<\/li>\n<\/ul>\n\n\n\n<p>Overall trajectory can be stable for long periods, but progression of atrial conduction disease may occur over time in some patients. The intensity of follow-up varies by clinician and case.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Sick Sinus Syndrome Common questions (FAQ)<\/h2>\n\n\n\n<p><strong>Q: What does Sick Sinus Syndrome mean in plain language?<\/strong><br\/>\nIt means the heart\u2019s natural pacemaker (the sinus node) is not reliably keeping a steady, appropriate rhythm. This can cause the heart to beat too slowly, pause, or fail to speed up with activity. It can also coexist with fast atrial rhythms like atrial fibrillation.<\/p>\n\n\n\n<p><strong>Q: Is Sick Sinus Syndrome the same as bradycardia?<\/strong><br\/>\nNot exactly. Bradycardia is a slow heart rate and can be normal in some people (for example, during sleep or in trained athletes). Sick Sinus Syndrome refers to sinus node dysfunction that is clinically meaningful\u2014often because it causes symptoms, inappropriate slowing, pauses, or an impaired response to exercise.<\/p>\n\n\n\n<p><strong>Q: Can Sick Sinus Syndrome come and go?<\/strong><br\/>\nYes. Sinus node dysfunction is often intermittent, influenced by sleep, autonomic tone, medications, and episodes of atrial arrhythmias. This is one reason ambulatory monitoring is frequently used to capture events.<\/p>\n\n\n\n<p><strong>Q: How is Sick Sinus Syndrome diagnosed?<\/strong><br\/>\nDiagnosis typically relies on documenting sinus node\u2013related rhythm abnormalities and correlating them with symptoms. Clinicians often use ECGs plus ambulatory monitors (Holter, patch monitors, event monitors, or implantable loop recorders). They also evaluate for reversible contributors such as medication effects or metabolic issues.<\/p>\n\n\n\n<p><strong>Q: Does Sick Sinus Syndrome mean I\u2019m having a heart attack?<\/strong><br\/>\nNot necessarily. Many cases are related to age-associated fibrosis or atrial remodeling rather than acute coronary occlusion. That said, ischemia involving the sinus node\u2019s blood supply can contribute in certain settings, so clinicians interpret rhythm findings alongside symptoms, risk factors, and overall clinical context.<\/p>\n\n\n\n<p><strong>Q: What is tachy\u2013brady syndrome?<\/strong><br\/>\nTachy\u2013brady syndrome is a Sick Sinus Syndrome pattern where fast atrial rhythms (often atrial fibrillation or flutter) alternate with slow sinus rhythms or pauses. Symptoms may occur during the fast rhythm (palpitations) or when it stops (pause-related dizziness or syncope). Management often considers both the tachyarrhythmia and the bradyarrhythmia.<\/p>\n\n\n\n<p><strong>Q: Will everyone with Sick Sinus Syndrome need a pacemaker?<\/strong><br\/>\nNo. Pacemaker decisions usually depend on documented symptom\u2013rhythm correlation and the overall clinical picture. Some people have mild or situational findings that are monitored, while others with clear symptomatic bradycardia or pauses may be considered for pacing. The specifics vary by clinician and case.<\/p>\n\n\n\n<p><strong>Q: Can medications cause or worsen Sick Sinus Syndrome?<\/strong><br\/>\nMedications that slow the heart rate can unmask or worsen sinus node dysfunction in susceptible patients. Common examples include beta blockers, certain calcium channel blockers, digoxin, and some antiarrhythmics. Clinicians typically review medication timing and dosing alongside rhythm data when evaluating bradycardia.<\/p>\n\n\n\n<p><strong>Q: What tests might be done beyond an ECG?<\/strong><br\/>\nBecause the rhythm problem may be intermittent, ambulatory monitoring is common. Depending on symptoms, clinicians may also order labs (such as thyroid and electrolytes), an echocardiogram to assess structure and function, or exercise testing if chronotropic incompetence is suspected. The choice of tests varies by protocol and patient factors.<\/p>\n\n\n\n<p><strong>Q: What does follow-up usually involve after diagnosis?<\/strong><br\/>\nFollow-up often focuses on symptom tracking, rhythm surveillance, and management of associated conditions such as atrial fibrillation or structural heart disease. If a pacemaker is used, periodic device checks evaluate function and stored rhythm information. The frequency and type of follow-up depend on stability, comorbidities, and treatment strategy.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sick Sinus Syndrome is a condition where the heart\u2019s natural pacemaker does not consistently generate or transmit normal impulses. It is a cardiac conduction disorder rather than a single rhythm diagnosis. It is commonly encountered when evaluating bradycardia (slow heart rate), syncope (fainting), dizziness, or unexplained fatigue. It often arises in ambulatory ECG monitoring and electrophysiology-oriented cardiology care.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-461","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/461","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/comments?post=461"}],"version-history":[{"count":0,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/461\/revisions"}],"wp:attachment":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/media?parent=461"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/categories?post=461"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/tags?post=461"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}